Planta Med 2011; 77(14): 1590-1593
DOI: 10.1055/s-0030-1270987
Biological and Pharmacological Activity
Original Papers
© Georg Thieme Verlag KG Stuttgart · New York

Farnesiferol A from Ferula persica and Galbanic Acid from Ferula szowitsiana Inhibit P-Glycoprotein-Mediated Rhodamine Efflux in Breast Cancer Cell Lines

Mohammad Yahya Hanafi-Bojd1 , Mehrdad Iranshahi1 , Fatemeh Mosaffa1 , Shahireh Omidvar Tehrani1 , Fatemeh Kalalinia1 , Javad Behravan1
  • 1Biotechnology Research Center and School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
Further Information

Publication History

received October 26, 2010 revised March 7, 2011

accepted March 17, 2011

Publication Date:
11 April 2011 (online)

Abstract

In multidrug resistance (MDR), cancer cells exposed to anticancer agents develop resistance to a wide variety of chemicals and chemotherapeutic agents. Sesquiterpene coumarins are reported to inhibit P-glycoprotein and/or increase cytotoxicity of anticancer drugs in P‐gp-overexpressing cell lines.

In the current study, we investigated the effects of galbanic acid (from the roots of Ferula szowitsiana) and farnesiferol A (from the roots of Ferula persica) on functionality of the drug transporter P-glycoprotein (P‐gp) using a rhodamine 123 efflux assay in a doxorubicin resistant breast cancer cell line (MCF7/Adr).

Compared to verapamil, the well-known inhibitor of P‐gp, galbanic acid (5, 10, and 25 µg/mL), significantly inhibited the P‐gp activity. In inhibition of the P‐gp transporter, farnesiferol A (0.5 µg/mL) was more potent than verapamil at 15 min exposure.

Our results indicate that the plant derived sesquiterpene coumarins, farnesiferol A and galbanic acid, may be promising candidates to be considered for further studies on the reversal of multidrug resistance phenotype in chemotherapy of cancer patients.

References

  • 1 Liscovitch M, Lavie Y. Cancer multidrug resistance: a review of recent drug discovery research.  Drugs. 2002;  5 349-355
  • 2 Ambudkar S V, Dey S, Hrycyna C A, Ramachandra M, Pastan I, Gottesman M M. Biochemical, cellular, and pharmacological aspects of the multidrug transporter.  Annu Rev Pharmacol Toxicol. 1999;  39 361-398
  • 3 Sharom F J. The P-glycoprotein efflux pump: how does it transport drugs?.  J Membr Biol. 1997;  160 161-175
  • 4 Thiebaut F, Tsuruo T, Hamada H, Gottesman M M, Pastan I, Willingham M C. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.  Proc Natl Acad Sci USA. 1987;  84 7735-7738
  • 5 Abd El-Razek M H, Ohta S, Hirata T. Terpenoid coumarins of the genus Ferula.  Heterocycles. 2003;  60 689-716
  • 6 Pimenov M G, Leonov M V. The asian umbelliferae biodiversity database (ASIUM) with particular reference to south-west asian taxa.  Turk J Bot. 2004;  28 139-145
  • 7 Barthomeuf C, Demeule M, Grassi J, Saidkhodjaev A, Beliveau R. Conferone from Ferula schtschurowskiana enhances vinblastine cytotoxicity in MDCK-MDR1 cells by competitively inhibiting P-glycoprotein transport.  Planta Med. 2006;  72 634-639
  • 8 Madureira A M, Molnar A, Abreu P M, Molnar J, Ferreira M J U. A new sesquiterpene-coumarin ether and a new abietane diterpene and their effects as inhibitors of P-glycoprotein.  Planta Med. 2004;  70 828-833
  • 9 Behnam Rassouli F, Matin M M, Iranshahi M, Bahrami A R, Neshati V, Mollazadeh S, Neshati Z. Mogoltacin enhances vincristine cytotoxicity in human transitional cell carcinoma (TCC) cell line.  Phytomedicine. 2009;  16 181-187
  • 10 Iranshahi M, Kalategi F, Rezaee R, Shahverdi A R, Ito C, Furukawa H, Tokuda H, Itoigawa M. Cancer chemopreventive activity of terpenoid coumarins from Ferula species.  Planta Med. 2008;  74 147-150
  • 11 Iranshahi M, Arfa P, Ramezani M, Jaafari M R, Sadeghian H, Bassarello C, Piacente S, Pizza C. Sesquiterpene coumarins from Ferula szowitsiana and in vitro antileishmanial activity of 7-prenyloxycoumarins against promastigotes.  Phytochemistry. 2007;  68 554-561
  • 12 Iranshahi M, Amin G, Shafiee A. A new coumarin from Ferula persica.  Pharm Biol. 2004;  42 440-442
  • 13 Gedeon C, Behravan J, Koren G, Piquette-Miller M. Transport of glyburide by placental ABC transporters: implications in fetal drug exposure.  Placenta. 2006;  27 1096-1102
  • 14 Ikegawa T, Ohtani H, Koyabu N, Juichi M, Iwase Y, Ito C, Furukawa H, Naito M, Tsuruo T, Sawada Y. Inhibition of P-glycoprotein by flavonoid derivatives in adriamycin-resistant human myelogenous leukemia (K562/ADM) cells.  Cancer Lett. 2002;  177 89-93
  • 15 Bradford M M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.  Anal Biochem. 1976;  72 248-254
  • 16 Kusuhara H, Suzuki H, Sugiyama Y. The role of P-glycoprotein and canalicular multispecific organic anion transporter in the hepatobiliary excretion of drugs.  J Pharm Sci. 1998;  87 1025-1040
  • 17 Ma Y, Wink M. Lobeline, a piperidine alkaloid from Lobelia can reverse P-gp dependent multidrug resistance in tumor cells.  Phytomedicine. 2008;  15 754-758
  • 18 Oughlissi-Dehak K, Lawton P, Michalet S, Bayet C, Darbour N, Hadj-Mahammed M, Badjah-Hadj-Ahmed Y A, Dijoux-Franca M G, Guilet D. Sesquiterpenes from aerial parts of Ferula vesceritensis.  Phytochemistry. 2008;  69 1933-1938
  • 19 Raub T J. P-glycoprotein recognition of substrates and circumvention through rational drug design.  Mol Pharm. 2006;  3 3-25

Professor Javad Behravan

Dept. Pharmaceutical Biotechnology
School of Pharmacy

P. O. Box 91775-1365

Mashhad

Iran

Phone: +98 51 18 82 32 55

Fax: +98 51 18 82 32 51

Email: behravanj@mums.ac.ir

    >